MAP2K5 and cancer: Interestingly, ectopic expression of MEK5 had been previously shown to promote a more malignant phenotype by repressing ERα expression and by promoting epithelial mesenchymal transition (EMT), a well-known reprograming process that confers metastatic properties to cancer cells [38–40].